Phenotypic drug discovery: recent successes, lessons learned and new directions
F Vincent, A Nueda, J Lee, M Schenone… - Nature Reviews Drug …, 2022 - nature.com
Many drugs, or their antecedents, were discovered through observation of their effects on
normal or disease physiology. For the past generation, this phenotypic drug discovery …
normal or disease physiology. For the past generation, this phenotypic drug discovery …
[HTML][HTML] Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: A systematic review
D Jeremic, L Jiménez-Díaz, JD Navarro-López - Ageing research reviews, 2021 - Elsevier
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …
affecting around 46 million people worldwide but few treatments are currently available. The …
Gut microbiota regulate Alzheimer's disease pathologies and cognitive disorders via PUFA-associated neuroinflammation
Objective This study is to investigate the role of gut dysbiosis in triggering inflammation in
the brain and its contribution to Alzheimer's disease (AD) pathogenesis. Design We …
the brain and its contribution to Alzheimer's disease (AD) pathogenesis. Design We …
Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury
C Li, Z Wu, L Zhou, J Shao, X Hu, W Xu… - Signal transduction and …, 2022 - nature.com
Spinal cord injury (SCI) involves diverse injury responses in different cell types in a
temporally and spatially specific manner. Here, using single-cell transcriptomic analyses …
temporally and spatially specific manner. Here, using single-cell transcriptomic analyses …
Bacteroides Fragilis in the gut microbiomes of Alzheimer's disease activates microglia and triggers pathogenesis in neuronal C/EBPβ transgenic mice
Gut dysbiosis contributes to Alzheimer's disease (AD) pathogenesis, and Bacteroides strains
are selectively elevated in AD gut microbiota. However, it remains unknown which …
are selectively elevated in AD gut microbiota. However, it remains unknown which …
Legumain is an endogenous modulator of integrin αvβ3 triggering vascular degeneration, dissection, and rupture
Background: The development of thoracic aortic dissection (TAD) is closely related to
extracellular matrix degradation and vascular smooth muscle cell (VSMC) transformation …
extracellular matrix degradation and vascular smooth muscle cell (VSMC) transformation …
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
The human gastrointestinal tract is populated with a diverse microbial community. The vast
genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every …
genetic and metabolic potential of the gut microbiome underpins its ubiquity in nearly every …
CRISPRi screens in human iPSC-derived astrocytes elucidate regulators of distinct inflammatory reactive states
Astrocytes become reactive in response to insults to the central nervous system by adopting
context-specific cellular signatures and outputs, but a systematic understanding of the …
context-specific cellular signatures and outputs, but a systematic understanding of the …
Gut inflammation triggers C/EBPβ/δ‐secretase‐dependent gut‐to‐brain propagation of Aβ and Tau fibrils in Alzheimer's disease
Inflammation plays an important role in the pathogenesis of Alzheimer's disease (AD). Some
evidence suggests that misfolded protein aggregates found in AD brains may have …
evidence suggests that misfolded protein aggregates found in AD brains may have …
Deficiency in BDNF/TrkB neurotrophic activity stimulates δ-secretase by upregulating C/EBPβ in Alzheimer's disease
ZH Wang, J Xiang, X Liu, SP Yu, FP Manfredsson… - Cell reports, 2019 - cell.com
BDNF/TrkB neurotrophic signaling regulates neuronal development, differentiation, and
survival, and deficient BDNF/TrkB activity underlies neurodegeneration in Alzheimer's …
survival, and deficient BDNF/TrkB activity underlies neurodegeneration in Alzheimer's …